Experience

Molecular Templates

• United States
• Biotechnology Research
• 1 - 100 Employee

• VP Process Technologies

  • Sep 2019 - Present

  Austin, Texas, United States

• VP Process Development

  • Sep 2019 - Sep 2020

  Austin, Texas, United States

• Vice President of Manufacturing

  • Dec 2017 - Sep 2019

  Austin, Texas, United States

• EVP Manufacturing

  • Jun 2016 - Dec 2017

  Austin, Texas Area

• VP Protein Engineering

  • Jan 2013 - Jun 2016

  Austin, Texas, United States

• Senior Director of Protein Engineering

  • Mar 2012 - Jan 2013

  (1) Protein engineering and fusion protein design. (2) Protein expression and purification from CHO-S cells, as well as bacteria soluble, inclusion body and periplasmic fractions. (3) Protein PEGylation and formulation.



Texas A&M University HSC

• Assistant Professor of Internal Medicine

  • Aug 2008 - Jan 2012

  Non-tenure-track Assistant professor (1) Teaching graduate school course (2) Director of Clinical Pharmacology, responsible for communicating with Medical Doctors, Clinical Research Coordinators and Lab Technicians to conduct clinical pharmacological studies. (3) Conducted independent research projects and published 5 manuscripts as Corresponding Author as well as 3 patent applications as the Lead Inventor.



Scott & White Healthcare

• United States
• Non-profit Organization Management

• R&D Research Scientist II

  • Oct 2005 - Jan 2012

  Leading the design, engineering and development of immunotoxins, therapeutic-targeting antigens, antibodies, bispecific antibody and antibody internalization assays. (1) Engineering a CD123 x CD3 Bispecific scFv Immunofusion for the Treatment of Leukemia and Elimination of Leukemia Stem Cells. (2) Humanized Anti-Caveolin 1 Antibodies as Anti-Metastatic Prostate Cancer Therapeutics. (3) Antibody Internalization Efficiency Analysis. Antibody internalization after cell surface… Show more Leading the design, engineering and development of immunotoxins, therapeutic-targeting antigens, antibodies, bispecific antibody and antibody internalization assays. (1) Engineering a CD123 x CD3 Bispecific scFv Immunofusion for the Treatment of Leukemia and Elimination of Leukemia Stem Cells. (2) Humanized Anti-Caveolin 1 Antibodies as Anti-Metastatic Prostate Cancer Therapeutics. (3) Antibody Internalization Efficiency Analysis. Antibody internalization after cell surface antigen binding is critical for immunotoxin development. My team has designed and developed a novel and simplified assay system to quantitatively analyze the cellular internalization efficiencies of antibody-cell surface antigen complexes. (4) Gene Delivery through Receptor-Mediated Endocytosis. (5) GMP production of IL3 Receptor-targeting immunotoxin for Acute Myeloid Leukemia. Show less